Ligand-specific factors influencing GLP-1 receptor post-endocytic trafficking 
and degradation in pancreatic beta cells

Fang, Zijian; Chen, Shiqian; Manchanda, Yusman; Bitsi, Stavroula; Pickford, Philip; David, Alessia; Shchepinova, Maria M.; Corrêa Jr, Ivan R; Hodson, David J; Broichhagen, Johannes; Tate, Edward W.; Reimann, Frank; Salem, Victoria; Rutter, Guy A.; Tan, Tricia; Bloom, Stephen R.; Tomas, Alejandra; Jones, Ben

doi:10.3390/ijms21218404

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Ligand-specific factors influencing GLP-1 receptor post-endocytic trafficking and degradation in pancreatic beta cells

MPS-Authors

/persons/resource/persons208663

Broichhagen, Johannes
Chemical Biology, Max Planck Institute for Medical Research, Max Planck Society;

External Resource

https://doi.org/10.3390/ijms21218404
(Any fulltext)

https://www.mdpi.com/1422-0067/21/21/8404/pdf
(Any fulltext)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Fang, Z., Chen, S., Manchanda, Y., Bitsi, S., Pickford, P., David, A., et al. (2020). Ligand-specific factors influencing GLP-1 receptor post-endocytic trafficking and degradation in pancreatic beta cells. International Journal of Molecular Sciences, 21(21): 8404, pp. 1-24. doi:10.3390/ijms21218404.

Cite as: https://hdl.handle.net/21.11116/0000-0009-A275-C

Abstract

The glucagon-like peptide-1 receptor (GLP-1R) is an important regulator of blood glucose homeostasis. Ligand-specific differences in membrane trafficking of the GLP-1R influence its signalling properties and therapeutic potential in type 2 diabetes. Here, we have evaluated how different factors combine to control the post-endocytic trafficking of GLP-1R to recycling versus degradative pathways. Experiments were performed in primary islet cells, INS-1 832/3 clonal beta cells and HEK293 cells, using biorthogonal labelling of GLP-1R to determine its localisation and degradation after treatment with GLP-1, exendin-4 and several further GLP-1R agonist peptides. We also characterised the effect of a rare GLP1R coding variant, T149M, and the role of endosomal peptidase endothelin-converting enzyme-1 (ECE-1), in GLP1R trafficking. Our data reveal how treatment with GLP-1 versus exendin-4 is associated with preferential GLP-1R targeting towards a recycling pathway. GLP-1, but not exendin-4, is a substrate for ECE-1, and the resultant propensity to intra-endosomal degradation, in conjunction with differences in binding affinity, contributes to alterations in GLP-1R trafficking behaviours and degradation. The T149M GLP-1R variant shows reduced signalling and internalisation responses, which is likely to be due to disruption of the cytoplasmic region that couples to intracellular effectors. These observations provide insights into how ligand- and genotype-specific factors can influence GLP-1R trafficking.